Published in TB and Outbreaks Week, June 21st, 2005
According to a study from South Africa, "Generic antiretroviral drugs are pivotal in the implementation of WHO's '3 by 5' program. However, clinical experience with generics in sub-Saharan Africa is insufficiently documented.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week